Division of Surgery, Oncology, and Pathology, Department of Clinical Sciences, Lund University, Solvegatan 19, Lund SE-223 62, Sweden.
Department Plastic and Reconstructive Surgery, Skåne University Hospital, Inga Marie Nilssons gata 47, Malmö SE-20502, Sweden.
J Proteome Res. 2021 May 7;20(5):2983-3001. doi: 10.1021/acs.jproteome.1c00243. Epub 2021 Apr 15.
Proteogenomic approaches have enabled the generat̲ion of novel information levels when compared to single omics studies although burdened by extensive experimental efforts. Here, we improved a data-independent acquisition mass spectrometry proteogenomic workflow to reveal distinct molecular features related to mammographic appearances in breast cancer. Our results reveal splicing processes detectable at the protein level and highlight quantitation and pathway complementarity between RNA and protein data. Furthermore, we confirm previously detected enrichments of molecular pathways associated with estrogen receptor-dependent activity and provide novel evidence of epithelial-to-mesenchymal activity in mammography-detected spiculated tumors. Several transcript-protein pairs displayed radically different abundances depending on the overall clinical properties of the tumor. These results demonstrate that there are differentially regulated protein networks in clinically relevant tumor subgroups, which in turn alter both cancer biology and the abundance of biomarker candidates and drug targets.
与单一组学研究相比,蛋白质基因组学方法能够产生新的信息层次,尽管需要进行大量的实验工作。在这里,我们改进了一种数据非依赖性采集质谱蛋白质基因组学工作流程,以揭示与乳腺癌 X 光表现相关的不同分子特征。我们的结果揭示了可在蛋白质水平检测到的剪接过程,并强调了 RNA 和蛋白质数据之间的定量和途径互补性。此外,我们证实了先前检测到的与雌激素受体依赖性活性相关的分子途径富集,并提供了在 X 光检测到的有毛刺肿瘤中上皮-间充质活性的新证据。一些转录-蛋白对的丰度根据肿瘤的整体临床特征表现出明显的差异。这些结果表明,在临床上相关的肿瘤亚组中存在差异调节的蛋白质网络,这反过来又改变了癌症生物学以及生物标志物候选物和药物靶点的丰度。